Introduction
Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2) 1 , also known as, macrophage actin-associated and tyrosine phosphorylated protein (MAYP) 2 , belongs to the Pombe Cdc15 homology (PCH) family of proteins that has recently been shown to coordinate membrane and cytoskeletal dynamics 3, 4 .
Several PCH proteins play important roles in immunity by regulating neutrophil migration 5 , T cell activation [6] [7] [8] , cell surface expression of Fas ligand 9, 10 and cytokine production 11, 12 . Mutations in PSTPIP1, the PCH family member most similar to PSTPIP2, lead to pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome in humans by promoting IL-1β processing 11, 13 .
PSTPIP2 is selectively expressed in macrophages and macrophage precursors 2, 12 and is an actin-bundling protein that regulates filopodia formation and macrophage motililty 14 . We have previously described the Lupo PSTPIP2 mutation in mice. This I282N missense mutation leads to a macrophagemediated autoinflammatory disease characterized by skin necrosis, inflammation of paws and ears and inflammatory bone resorption 12 , PSTPIP2 expression in
PSTPIP2
Lupo/Lupo bone marrow-derived macrophages (BMM) was reduced 3-fold due to the instability of the mutant protein. In addition, Lupo macrophages exhibited increased constitutive production of markers of macrophage activation, MCP-1 and soluble TNF-α receptor type I (sTNFR I) 12 , suggesting that PSTPIP2 negatively regulates macrophage activation. Consistent with this conclusion, compared to wt mice, Lupo mice had elevated levels of circulating MCP-1 and
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Another mutation in PSTPIP2, L98P, was described in the chronic multifocal osteomyelitis (cmo) mouse 15, 16 . The cmo mouse initially develops inflammation in the caudal vertebrae and phalanges with mixed inflammatory infiltrate of polymorphonuclear leukocytes, macrophages, lymphocytes, plasma cells, and osteoclasts. Later, the inflammatory infiltrate is replaced by new bone and fibrous tissue leading to tail kinks and hind-foot deformities. Subsequently, the mouse develops inflammation of the ears involving the dermis, epidermis and cartilage 15, 16 . Here we demonstrate that cmo disease, like Lupo disease, is autoinflammatory. We further show that the PSTPIP2 deficiency causes enhanced CSF-1 signaling, the expansion of early macrophage precursors and increased proinflammatory cytokine release by activated macrophages. These characteristics of cmo mice are expected to engender hyperresponsiveness to trauma and infection and to contribute to the onset and relapses characteristic of this type of inflammatory disease.
Materials and Methods

Materials
Unless otherwise specified, all reagents were purchased from Sigma (St. Louis, MO).
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Mice and genotyping
BALB/cAnPt-cmo, BALB/cByJ and Rag1-/-mice were obtained from Jackson Laboratories (Bar Harbor, ME) and maintained under specific pathogen-free conditions in a barrier facility at Einstein. Mouse breeding and the study protocols were approved by the Animal Institute at Einstein College of Medicine. Pstpip2 mutation genotyping was performed by PCR amplification and sequencing using oligonucleotides sequences 5'-CATGTCAAGGTGACAATGAAATC-3' and 5'-ACACCTGAGGCTT CTCTGTAGAA-3'.
For bone marrow transfers, four-week-old BALB/cAnPt-cmo or BALB/cByJ mice were irradiated with 1100 cGy in a split dose and transplanted with ~ 5x10 6 Ficoll separated, T cell depleted (anti-Thy1.2), mononuclear bone marrow cells i.v. 2
hours after irradiation as previously described 17 . Mice were housed in specific pathogen-free barrier cages after transplant and Baytril added in their drinking water. Mice were inspected twice each week for the following 12 weeks postirradiation for evidence of the cmo phenotype, including the presence of tail kinks, paw deformities or ear inflammation.
To examine the effect of Rag1 deficiency, cmo mice were crossed with C57BL6 
Histology
Mice were euthanized by CO 2 inhalation, then perfused with periodate-lysineparaformaldehide-glutaradehyde (PLPG) fixative by injection of the fixative in the heart 53 . Tissues were dissected, further fixed by immersion in PLPG, and embedded in paraffin. Sections, stained with F4/80 antibody (a gift from Dr.
David A. Hume, Univ. of Edinburgh, Scotland) and counterstained with hematoxylin were analyzed by light microscopy as previously described 12 .
Thioglycollate challenge
Mice (96-106 days old) were injected intraperitoneally with 1ml of 3.8% Brewers thioglycollate broth (Becton Dickinson, Franklin Lakes, NJ). After three days, mice were sacrificed by exposure to CO 2 and their peritoneal cells harvested by lavage with 10 ml of phosphate buffered saline (PBS). Red blood cells were lysed and the leukocytes were counted using a cell counter (Beckman Coulter, Fullerton, CA). Aliquots of 10 6 cells were stained with F4/80 (Caltag, Burlingame, CA), CD11b (Mac1) and Ly6G (Gr1) antibodies (BD Pharmingen, Franklin Lakes, NJ), fixed and analyzed by flow cytometry.
Hematopoietic progenitor assays
Asymptomatic (6-9 weeks old) cmo mice and wt controls of matched sex and age were euthanazied by CO 2 inhalation. Bone marrow cells and splenocytes were counted in 3% acetic acid-containing trypan blue using a hemocytometer. HPP-CFC and CFU-M in bone marrow and splenic cell suspensions were determined
For personal use only. on June 12, 2017 . by guest www.bloodjournal.org From using agar cultures as described 18 . HPP-CFC cultures contained SCF (50ng/ml) and IL-3 (20ng/ml) (StemCell Technologies, Vancouver, BC). In some cultures, CSF-1 (a gift from Chiron Corporation, Emeryville, CA). (18ng/ml) and/or IL-6 (20ng/ml) were added. CFU-M cultures contained CSF-1 (18ng/ml) with or without IL-6 (20ng/ml) (StemCell Technologies, Vancouver, BC). Colony number and morphology were determined by light microscopy using an Olympus CK2 inverted microscope and a 4x objective (Nikon, Melville, NY). Images of CFU-M colonies were acquired with a Kodak DC290 digital camera equipped with an adaptor for microscope. HPP-CFC colonies were scanned using an Epson Perfection 4990 scanner. Colony size was measured on digital images using Image J 19 .
Analysis of monocyte and macrophage populations by flow cytometry
Cell suspensions of bone marrow cells were diluted in staining buffer (5% newborn calf serum (Hyclone Laboratories Inc, Logan, UT) in balanced salt solution containing 0.1% NaN 3 ) were stained by incubation (20 min 
BMM preparation, immortalization and retroviral infection
BMM from PSTPIP2
cmo/cmo mice and wt controls were derived 22 and cultured as previously described 12 . Day 10 BMM were immortalized with SV-U19.5 retrovirus encoding large T antigen 23 and cells from representative cloned cell lines were subsequently infected with an MSCV-IRES-GFP retroviral vector encoding myctagged PSTPIP2 as described 14 . Clones expressing myc-PSTPIP2 at levels comparable to those of wt BMM or higher were selected to assess the capacity of retrovirally expressed PSTPIP2 to restore normal cytokine production.
Measurement of cytokines
Cell culture supernatants and mouse sera were initially screened for cytokine production using mouse inflammation antibody arrays (RayBiotech, Norcross, GA) or multiplexed beadlyte mouse cytokine kits (Millipore, Billerica, MA).
For personal use only. on June 12, 2017 . by guest www.bloodjournal.org From Subsequent evaluation of MIP1-α and IL-6 production by immortalized BMM, was performed using ELISA kits purchased from R&D Systems (Minneapolis, MN) and eBioscience (San Diego, CA), respectively. For LPS stimulation, primary or immortalized BMM were incubated with 1μg/ml LPS as described 12 and the supernatants assayed as described above.
Proliferation assays
Either day 3 BMM 22 and splenocyte-derived macrophages (SDM, prepared as (10ng/ml). From day 3, the medium was changed daily. At daily interval, cells were lysed in 0.005% Zwittergent (Calbiochem, San Diego, CA) in PBS and the nuclei counted with a cell counter. Doubling times were determined from the regions of the growth curves exhibiting logarithmic-phase growth.
CSF-1 stimulation of SDM, immunoprecipitation and Western Blots
SDM were prepared as described above except that SCF (10ng/ml) was added during the first three days of culture to promote the expansion of early myeloid precursors. Day 3 nonadherent cells were plated in 6 well tissue culture dishes in 15% FCS-α-MEM with 120ng/mlCSF-1. After 7 days of culture, the adherent cells 
Results
Absence of PSTPIP2 in cmo myeloid cells
The L98P cmo mutation resides in a predicted alpha helical coiled-coil domain of PSTPIP2 (aminoacids 93-121) and is expected to drastically alter the folding of PSTPIP2 by destabilizing the alpha helix 4, 15 . Indeed, we failed to detect PSTPIP2 protein expression by western blot analysis of whole cell lysates from cmo BMM, bone marrow-derived mast cells, or osteoclasts, while wt PSTPIP2 was readily detectable ( Fig.1 A) . To increase the sensitivity of detection of PSTPIP2, it was immunoprecipitated from NP-40 soluble lysates of BMM using an anti-PSTPIP2
antibody to a C-terminal peptide located at ~200 aminoacids from the cmo mutation 14 . PSTPIP2 was not detectable in immunoprecipitates from cmo BMM despite its abundance in immunoprecipitates from wt BMM (Fig. 1 B) .
cmo disease is autoinflammatory and involves extramedullary hematopoiesis and macrophage accumulation
We have previously shown that the Lupo inflammatory disease is associated with macrophage accumulation in affected tissues and can be cured by macrophage depletion 12 .
Immunohistological examination of the kinked tails of cmo mice indicated that they similarly accumulate macrophages at sites of inflammation ( Fig. 1C) . Also, associated with extensive splenic accumulation of F4/80 positive macrophages, from 3 months of age, cmo mice developed a significant splenomegaly (Fig. 1D ).
To investigate whether lymphocytes and autoantibodies are necessary for the development of disease in cmo mice, we crossed the cmo mutation onto the 
PSTPIP2-deficient cmo macrophages exhibit increased constitutive and LPS-induced proinflammatory mediator production that is corrected by reexpression of PSTPIP2
PSTPIP2 is highly expressed in macrophages and upregulated during the late phase of the LPS response 12 . To determine whether the cmo disease is associated with aberrant cytokine production by macrophages, we tested the constitutive and LPS-induced cytokine production by wt and cmo BMM against a panel of 40 inflammatory mediators (Fig. 2) . cmo BMM grown in the presence of CSF-1 released significantly more MIP-1α, MCP-1 and sTNFR I than wt macrophages ( Fig. 2A) . In addition, LPS induced a greater increase in IL-6 and MIP-1α production in cmo than in wt macrophages (Fig. 2B) . Similar results were obtained with splenocyte-derived macrophages (data not shown). Importantly, retroviral expression of PSTPIP2 in immortalized cmo macrophages (Fig. 2C) restored normal LPS-induced cytokine production (Fig. 2D) , demonstrating that PSTPIP2 is a negative regulator of classical macrophage activation.
PSTPIP2 deficiency leads to elevated levels of circulating inflammatory mediators in vivo
To address the significance of the increased inflammatory mediator production by macrophages for disease development in vivo, we examined the levels of (Fig. 2E ) and, significantly, only those two mediators exhibited increased LPS-stimulated release in cultured cmo macrophages compared to wt macrophages (Fig. 2 B) . Symptomatic PSTPIP2-deficient mice exhibited elevated levels of circulating IL-6, MIP-1α TNF-α, CSF-1 and IP-10 and decreased levels of IL-13, a T cell cytokine that induces alternative macrophage activation [25] [26] [27] (Fig. 2E) . These results suggest that increased production of MIP-1α and IL-6 play an important role in the initiation of cmo disease while the increased levels of TNF-α, CSF-1 and IP-10 in diseased mice could be the consequence of ongoing inflammation.
Increased numbers of monocyte/macrophage progenitors with greater
proliferative potential precedes the onset of disease.
Macrophage accumulation in the inflamed tissues and spleens of cmo mice in the absence of a corresponding increase in macrophage chemotaxis to CSF-1 (Fig. S1 ), suggested that macrophage production or proliferation may be altered in PSTPIP2-deficient mice. To address this possibility, we first compared the numbers of CSF-1-responsive colony forming cells (CFU- (Fig. 3) .
There was an ~3-fold increase in the numbers of CFU-M in the spleens of asymptomatic cmo compared with wt mice and a further ~12 fold increase in symptomatic mice (Fig. 3A) . There was no effect of disease on bone marrow cellularity; however, consistent with the increase in their splenic mass (Fig. 1D) and CFU-M numbers (Fig. 3A) , symptomatic cmo mice had increased splenic cellularity (Fig. 3B) . These data indicate that there is an early appearance and progressive accumulation of CSF-1-responsive macrophage progenitors in the spleens of cmo mice. In contrast, there was no change in the number of CFU-M in bone marrow with increasing severity of disease. However, the frequency of As IL-6 was elevated in the circulation of asymptomatic mice (Fig.2E ) and monocytes have been reported to produce IL-6 constitutively 29 , we also examined the involvement of IL-6 in the proliferation of myeloid precursors in wt and cmo mice (Table 1 ). IL-6 has been shown to enhance the effect of other cytokines on HPP colony formation 30 . Consistent with this, in splenocyte cultures HPP-CFC number and colony size were increased for both wt and cmo. In contrast, there was no effect of IL-6 on HPP-CFC number or colony size in either wt or cmo bone marrow cultures. As previously reported 31 , exogenous IL-6 decreased CFU-M numbers in wt bone marrow and splenocyte cultures (Table   1 ). In contrast, the effects of IL-6 on CFU-M numbers as well as colony size were attenuated in cmo cultures. The effect of IL-6 on colony size was less dramatic For personal use only. on June 12, 2017. by guest www.bloodjournal.org From in cmo cultures due to an ~3-fold larger colony size in the absence of IL-6. The development of larger colonies in cmo cultures in the absence of IL-6 was not due to endogenous production of IL-6 in the cmo cultures as neutralizing antibodies to IL-6 or the IL-6 receptor (gp130) failed to reduce cmo colony size (data not shown). These findings are consistent with the existence of higher numbers of more primitive macrophage progenitors in the spleens of cmo compared to wt mice.
PSTPIP2 negatively regulates macrophage proliferation
To determine whether the increase in colony size observed in the macrophage progenitor assays reflected significant changes in the proliferative responses of PSTPIP2-deficient macrophage precursors in bone marrow and spleens of cmo mice, we examined the proliferation of purified bone marrow and splenic promonocytes in the presence of CSF-1. The rate of CSF-1-stimulated macrophage proliferation was significantly increased in both splenic (Fig. 4A ) and bone marrow (Fig. 4B ) macrophages of cmo mice (Table 1 ). In contrast, there was no difference in the proliferation rate of wt and cmo promonocytes grown in the presence of GM-CSF or IL-3 (data not shown). The increased CSF-1-induced proliferation by cmo macrophages was maintained when nonadherent bone marrow (doubling times, wt 21h vs cmo 18h, in the presence of CSF-1 alone, or wt 27h vs cmo 25h, in the presence of CSF-1 and IL-6) or splenic cells (doubling times, wt 29h vs cmo 23h, in the presence of CSF-1 alone, or wt 41h vs cmo 29h, in the presence of CSF-1 and IL-6) were cultured in the presence of CSF-1
For personal use only. on June 12, 2017. by guest www.bloodjournal.org From and IL-6, although IL-6 suppressed proliferation ( Fig. 4A and B) . Interestingly, splenocyte macrophages exhibited larger differences between cmo and wt proliferation rates than bone marrow derived macrophages. In contrast, overexpression of PSTPIP2 in the splenic macrophage cell line BAC1.2F5 24 significantly decreased the rate of cell proliferation (39±1h vs 29±1.6h in wt) (Fig.   4C ). These data indicate that PSTPIP2 negatively regulates CSF-1-induced macrophage proliferation.
Enhanced activation of Erk1/2 and STAT1 by CSF-1 signaling in cmo macrophages lacking PSTPIP2
To determine how PSTPIP2 attenuates macrophage proliferation, we stimulated day 10 splenocyte-derived macrophages (SDM) with CSF-1 or IL-6 and analyzed the activation of downstream pathways that regulate macrophage proliferation and activation. There was no difference in the level of cell surface CSF-1R expression between wt and cmo macrophages (data not shown). However, PSTPIP2 deficiency in splenic macrophages led to increased expression of STAT1 (1.8±0.2 fold vs wt, n=3), but not STAT3 levels (Fig. 5A ). In addition, PSTPIP2 deficiency enhanced the ability of CSF-1 to stimulate ERK1/2 phosphorylation(1.5±0.2 fold vs wt, n=3) and STAT1 phosphorylation (2.2±0.6
fold vs wt, n=3) (Fig. 5A ). These responses were specific for CSF-1, as the IL-6-induced phosphorylation of ERK1/2 and STAT1 was not affected by PSTPIP2 deficiency (Fig. 5A) . The increase in ERK1/2 phosphorylation occurred without any alteration in the kinetics (data not shown). Despite the negative regulation of For personal use only. on June 12, 2017. by guest www.bloodjournal.org From STAT1 phosphorylation by PSTPIP2, we could not detect significant differences between wt and cmo splenic macrophages in their phosphorylation of tyrosine 706 of CSF-1R, a site previously reported to selectively enhance STAT1 activation 32 (Fig. 5) . In contrast, overexpression of PSTPIP2 in BAC1.2F5
macrophages reduced both the expression of STAT1 (0.4±0.05 fold vs wt, n=3) and the CSF-1-induced phosphorylation of Erk1/2 (0.6±0.1 fold vs wt, n=3) (Fig.   5B ). These data are consistent with negative regulation of STAT1 expression and Erk1/2 activation by PSTPIP2.
Increased recruitment of immature macrophages in cmo mice in response to a local inflammatory stimulus
The expansion of early macrophage progenitors could prime cmo mice to mount exaggerated local inflammatory responses. While we have found that cmo macrophages exhibit decreased chemotactic responses to CSF-1, they produce more MIP-1α, a chemoattractant for monocytes and granulocytes. To address the role of PSTPIP2 in an acute inflammatory response, we induced sterile peritonitis in wt and cmo mice using thioglycollate broth. Monocyte recruitment to the peritoneum was not affected by PSTPIP2 deficiency (Fig. 6A) Cultures from these patients are negative and bacterial ribosomal DNA was not detected in bone biopsies 35 . Trauma has been reported as an inciting factor for bone lesions in 25% of CRMO patients 36 . Evidence for a genetic component derives from familial studies which established a susceptibility region on chromosome 18q 34, 37 , where pstpip2 is located and from an autosomal recessive form of the disease called Majeed syndrome, that is caused by mutations in LPIN2 38 . However, in the limited number of cases studied, mutations in PSTPIP2
have not yet been implicated 39 . Irrespective of the connection between PSTPIP2
and CRMO, studies of mice bearing mutations in PSTPIP2 promise to reveal novel cellular processes and pathways that are dysregulated in autoinflammatory disease.
We previously showed that the I282N mutation (Lupo) of PSTPIP2, was associated with a 3-fold reduction in PSTPIP2 expression and led to an autoinflammatory disease 12 .
PSTPIP2
Lupo/Lupo mice exhibited increased inflammatory mediator production by macrophages and extensive macrophage infiltration in the affected tissues, suggesting that PSTPIP2 is anti-inflammatory 12 
.
For
PSTPIP2
Lupo/Lupo mice, the inflamed tissues of PSTPIP2 cmo/cmo mice contain large numbers of F4/80-positive macrophages (Fig. 1D ). In addition, macrophage precursors infiltrate the spleen and cause splenomegaly in the cmo mice (Fig.3) .
Consistent with the predicted disruption of PSTPIP2 protein folding and stability by the L98P mutation causing cmo disease 15, 34, 40 , we could not detect PSTPIP2
protein expression in cmo myeloid cells (Fig. 1) . This absence of PSTPIP2 leads to increased constitutive and LPS-stimulated production of several inflammatory mediators by cmo macrophages (Fig. 2) . Importantly, circulating levels of MIP1-α and IL-6, are elevated in cmo mice prior to the development of overt disease,
suggesting that the activation of macrophages contributes to disease development. That activated macrophages, rather than mast cells, or granulocytes, play a central role in disease development is emphasized by the observations that IgE receptor-induced mast cell degranulation is reduced in cmo bone marrow-derived mast cells (data not shown) and that PSTPIP2 is not expressed in Mac1 low Gr1 hi polymorphonuclear cells 12 .
The extensive macrophage accumulation in inflamed tissues of cmo mice could be due increased production of monocyte chemotactic factors, such as MIP1-α, by macrophages at these sites. However, the splenomegaly in cmo mice raised the possibility that a cell-autonomous effect of the loss of PSTPIP2 on the myeloid lineage leading to increased monopoiesis and/or increased macrophage proliferation, could also contribute, by systemically "priming" the mice for responses to local inflammatory stimuli. Bone marrows of asymptomatic cmo mice contained early myeloid precursors (HPP-CFC) that hyperproliferated in the For personal use only. on June 12, 2017. by guest www.bloodjournal.org From presence of CSF-1. In addition, the spleens of asymptomatic cmo mice contained higher numbers of HPP-CFC and CFU-M that also hyperproliferated in the presence of CSF-1 (Table 1) . Consistent with this, nonadherent bone marrow and splenic cells proliferated faster than wt counterparts in the presence of CSF-1 (Fig.4 and Table 1 ). Other investigators have shown that, PSTPIP2 mRNA levels are significantly upregulated during the differentiation of stem cells to late hematopoietic progenitors 41 and during GM-CSF-induced differentiation of hematopoietic cells in vitro 42 . Together, these data suggest that the upregulation of PSTPIP2 expression during myeloid differentiation promotes the differentiation and/or suppresses the proliferation of early macrophage progenitors. CSF-1 and receptor activator of NF-kappaB ligand (RANKL) regulate osteoclastogenesis 43, 44 and osteoclasts have been noted at sites of inflammation in the bones of both . The upregulation of monocytopoiesis in cmo mice provides a source of progenitors for the osteoclasts, the recruitment and generation of which would be enhanced by MIP1-α 45 , which is produced in increased amounts by cmo macrophages. In addition, IL-6, a cytokine that promotes inflammation-induced osteclastogenesis 46 is also produced in increased amounts by cmo macrophages (Fig. 2) . Apart from the suppression of CSF-1-regulated progenitor cell proliferation by PSTPIP2, our comparison of the proliferation rates of purified wt and cmo bone marrow and splenic promonocytes in the presence of CSF-1 indicated that PSTPIP2 also negatively regulates macrophage proliferation.
For personal use only. on June 12, 2017 . by guest www.bloodjournal.org From Thus it appears that the myeloid system of cmo mice is primed to provide monocytes for recruitment to sites of local inflammation and in addition, the macrophages at those sites are able to release elevated levels of proinflammatory cytokines, including chemotactic factors, which can further increase recruitment. However, as PSTPIP2 promotes macrophage motililty 14 ( Fig. S1 ) its absence in cmo macrophages may counterbalance the effect of increased chemotactic factors. Indeed, in the inflammatory response to thioglycollate challenge, cmo mice recruited comparable numbers of F4/80-positive macrophages to the peritoneum but, consistent with their primed monocytopoiesis, the proportion of immature macrophages was higher than in wt mice (Fig. 6 ).
The increased response of cmo macrophages to activation by LPS, together with the hematopoietic phenotype of cmo mice was reminiscent of the hematopoietic phenotype of STAT3-deficient mice, in which hyperproliferation of myeloid cells and increased responsiveness to LPS [47] [48] [49] were also observed.
Furthermore, failure of IL-6 activation of STAT3, due to an IL-6 receptor (gp130) mutation, also induced a cmo-like expansion of macrophage progenitor cells and increased macrophage proliferation in association with increased Erk1/2 activation and overexpression of c-fms 31 . However, our analysis of downstream signaling pathways leading to cell proliferation indicated that STAT3 levels and phosphorylation as well as c-fms expression were normal in cmo macrophages.
In contrast, STAT1 was significantly upregulated and CSF-1-stimulated phosphorylation of STAT1 and Erk1/2 were significantly increased. In addition to promoting macrophage development, survival and proliferation, CSF-1 also stimulates MIP1-α and TNF-α production by macrophages and increases IL-6 production by monocytes (ref. 43 and data not shown). Although the mechanism is not known, STAT1 could play an important role, since STAT-1-and Akt-mediated macrophage priming by IFN-β is necessary for optimal LPS-stimulated production of several inflammatory mediators, including IL-6 52 and for poly (I:C)-induced MIP1-α mRNA expression in keratinocytes 53 . In contrast, STAT3 is dispensable for CSF-1-induced macrophage proliferation 50 and MIP1-α expression 54 , and has anti-proliferative and anti-inflammatory effects in macrophages 31, 49, 55, 56 . Thus, our data suggest that upregulation of STAT1 in cmo macrophages could contribute to their increased production of IL-6 and MIP1-α.
In summary, the loss of macrophage regulation by PSTPIP2 promotes cmo disease development at two levels. At one level, there is over production of macrophage and osteoclast progenitors and at the other level, increased macrophage production of inflammatory cytokines, that act both to enhance
For personal use only. on June 12, 2017. by guest www.bloodjournal.org From monopoiesis and to recruit macrophages and osteoclast precursors to sites of inflammation (Fig. 7) . Analysis of PSTPIP2 function should provide insight into novel pathways involved in these processes. 
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